We got here throughout a bullish thesis on IDEXX Laboratories, Inc. on MTC’s Substack. On this article, we are going to summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.’s share was buying and selling at $643.59 as of February fifth. IDXX’s trailing and ahead P/E had been 49.20 and 45.25 respectively in keeping with Yahoo Finance.
Photograph by Karlo Tottoc on Unsplash
IDEXX Laboratories, Inc. develops, manufactures, and distributes merchandise for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in america and internationally. IDXX delivered a powerful end to 2025, surpassing analyst expectations with fourth-quarter income of $1.09 billion, up 14% reported and 12% organically, and EPS of $3.08, exceeding the consensus of $2.93. Full-year income reached $4.30 billion, up 10% each reported and organically, with EPS of $13.08, a 14% enhance over 2024, whereas working margins expanded to 31.6% by income progress and productiveness enhancements.
The Companion Animal Group (CAG) remained the first progress engine, producing $998 million in This fall income with 13% natural progress, pushed by recurring diagnostic income progress, quantity good points, and 4% common world web value enchancment. IDEXX set a quarterly document for premium instrument placements, with over 1,900 inVue Dx devices added, contributing to 69% natural progress in CAG Diagnostic instrument revenues and increasing the worldwide put in base by 12% for the yr. Margins strengthened throughout the board, with This fall gross margin rising to 60.3% and working margin reaching 29%, supported by quantity good points, productiveness initiatives, and value realization.
The corporate generated $1.1 billion in free money move for 2025, absolutely changing web earnings to money, whereas returning $1.2 billion to shareholders by share repurchases. Wanting forward, IDEXX expects 2026 income of $4.63–$4.72 billion, reflecting 7%–9% natural progress, and EPS of $14.29–$14.80, supported by continued margin growth. Different segments carried out solidly, with Water up 10% organically and Livestock, Poultry & Dairy rising 4% organically. Strategic investments in innovation, together with the inVue Dx platform and CancerDx check, are poised to drive future progress, whereas the corporate maintains disciplined industrial and operational execution, positioning IDEXX for continued worthwhile growth.
Beforehand, we lined a bullish thesis on IDEXX Laboratories, Inc. (IDXX) by Hidden Market Gems in March 2025, which highlighted the corporate’s management in veterinary diagnostics, recurring income mannequin, sturdy margins, innovation in AI-driven and cloud-based options, and progress alternatives throughout Companion Animal, livestock, and water markets. IDXX’s inventory value has appreciated by roughly 50.83% since our protection. MTC shares an analogous perspective however emphasizes IDEXX’s document instrument placements, sturdy 2025 monetary outcomes, and strong free money move as near-term catalysts.
